🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zachary N. Warnken

Cassava Sciences (United States)

ORCID: 0000-0002-1028-134X

Also affiliated with Mirna Therapeutics (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients”.

Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients

AAPS PharmSciTech(2020)10.1208/s12249-020-01682-4
N/A
0DataRank · unranked
19 citations

Patricia P. Martins, Michael Zamloot, Shawn A. Kucera, Robert O. Williams, Hugh D. C. Smyth +2 more

Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae

PLoS ONE(2021)10.1371/journal.pone.0246803
N/A
0DataRank · unranked
65 citations

Hyojong Seo, Zachary N. Warnken, Li Ding, Sang Heui Seo, Hugh D. C. Smyth +1 more

Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics

European Journal of Pharmaceutical Sciences(2023)10.1016/j.ejps.2023.106470
N/A
0DataRank · unranked
10 citations

Andrea N. Trementozzi, Patricia P. Martins, Jagruti Parekh, John J. Koleng, Hugh D. C. Smyth +2 more